Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|November 7, 2022
An update on the interaction between COVID-19, vaccines, and diabetic kidney diseaseYang Yang, Shubiao Zou, Gaosi Xu
Biotechnology and Applied Biochemistry|May 24, 2019
miR-885-5p plays an accomplice role in liver cancer by instigating TIGAR expression via targeting its promoterShubiao Zou, Yao Rao, Weicai Chen
American Journal of Physiology. Renal Physiology|January 25, 2018
Short-term high-glucose treatment decreased abundance of Orai1 protein through posttranslational mechanisms in rat mesangial cellsHui Jiang, Shubiao Zou, Sarika Chaudhari, et al.
Clinical and Experimental Medicine|June 18, 2025
Innovative technologies and their clinical prospects for early lung cancer screeningZisu Deng, Xiaocao Ma, Shubiao Zou, et al.
Frontiers in Immunology|December 5, 2024
The role of macrophages in liver fibrosis: composition, heterogeneity, and therapeutic strategiesXiaocao Ma, Jia Qiu, Shubiao Zou, et al.
Toxicology|November 30, 2025
2,4,6-triiodophenol induces glomerular mesangial cell damage through inflammatory imbalance, oxidative stress overactivation, and aberrant apoptosisTingting Miao, Shubiao Zou, Binwu Xu, et al.
Molecular and Cellular Biochemistry|July 16, 2011
SP1 plays a pivotal role for basal activity of TIGAR promoter in liver cancer cell linesShubiao Zou, Zhidong Gu, Peihua Ni, et al.
Molecular Biosystems|May 5, 2017
Reconstruction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in rheumatoid arthritisHui Jiang, Rong Ma, Shubiao Zou, et al.
Biochemical and Biophysical Research Communications|September 17, 2013
CREB, another culprit for TIGAR promoter activity and expressionShubiao Zou, Xiaozhong Wang, Linqiang Deng, et al.
Bioorganic Chemistry|December 28, 2025
Recent process in the development of TIM-3 antibodies and small-molecule inhibitors for cancer immunotherapyFei Huang, Hao Li, Tingting Miu, et al.
Pageof 1